AliveCor Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 178

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $25M

  • Investors
  • 12

AliveCor General Information

Description

Developer of a mobile electrocardiogram device designed to improve stroke prevention through early atrial fibrillation detection. The company's device lets patients monitor their heart health via their smartphones and provides physicians with an additional heart health assessment tool, enabling doctors to instantly analyze and detect atrial fibrillation and normal sinus rhythm in an ECG.

Contact Information

Formerly Known As
AliveUSA
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 189 Bernardo Street
  • Suite 100
  • Mountain View, CA 94043
  • United States
+1 (650)
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Wearables & Quantified Self, TMT, HealthTech, Mobile
Corporate Office
  • 189 Bernardo Street
  • Suite 100
  • Mountain View, CA 94043
  • United States
+1 (650)

AliveCor Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AliveCor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Debt - General 12-Oct-2022 $25M Completed Generating Revenue
10. Later Stage VC (Series F) 16-Aug-2022 Completed Generating Revenue
9. Later Stage VC (Series E) 16-Nov-2020 Completed Generating Revenue
8. Later Stage VC 15-Oct-2019 Completed Generating Revenue
7. Debt - General 28-Jan-2019 Completed Generating Revenue
6. Later Stage VC (Series D) 30-Mar-2017 Completed Generating Revenue
5. Later Stage VC (Series C) 14-Apr-2016 Completed Generating Revenue
4. Debt - General 15-Apr-2015 Completed Generating Revenue
3. Early Stage VC (Series B) 11-Jun-2012 $53.9M $66.2M Completed Generating Revenue
2. Early Stage VC (Series A) 11-Aug-2011 $8.7M $12.2M Completed Generating Revenue
To view AliveCor’s complete valuation and funding history, request access »

AliveCor Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F
Series E
Series D
Series C2
Series C1
Series C
Series B1 1,955,187 $0.000500 $0.8 $10.01 $10.01 1x $10.01 2.94%
Series A1 528,730 $0.000500 $0.4 $5 $5 1x $5 0.79%
To view AliveCor’s complete cap table history, request access »

AliveCor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a mobile electrocardiogram device designed to improve stroke prevention through early atrial fibrillation d
Monitoring Equipment
Mountain View, CA
178 As of 2024

Noida, India
 

Campbell, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AliveCor Competitors (16)

One of AliveCor’s 16 competitors is Agatsa, a Venture Capital-Backed company based in Noida, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agatsa Venture Capital-Backed Noida, India
CardioDiagnostics Venture Capital-Backed Campbell, CA
BodiMetrics Venture Capital-Backed Manhattan Beach, CA
Huinno Venture Capital-Backed Seoul, South Korea
EHRV Venture Capital-Backed Asheville, NC
You’re viewing 5 of 16 competitors. Get the full list »

AliveCor Patents

AliveCor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240152586-A1 Ecg-based biometric authentication Pending 08-Nov-2022
US-20240041331-A1 Multi-parameter monitoring device Pending 04-Aug-2022
US-20230326601-A1 Detection of cardiac conditions from reduced lead set ecg Pending 07-Apr-2022
US-20230263448-A1 Six lead ecg device with a reduced form factor Pending 28-Jan-2022
US-20230238133-A1 Ecg search and interpretation based on a dual ecg and text embedding model Pending 26-Jan-2022 G16H50/20
To view AliveCor’s complete patent history, request access »

AliveCor Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AliveCor Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
GE HealthCare Technologies Corporation Minority
Pegasus Tech Ventures Corporate Venture Capital Minority
Sweetwater Private Equity Secondary Buyer Minority
Huami Corp Corporation Minority
Mayo Clinic Corporation Minority
You’re viewing 5 of 12 investors. Get the full list »

AliveCor Acquisitions (1)

AliveCor’s most recent deal was a Merger/Acquisition with CardioLabs. The deal was made on 02-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CardioLabs 02-Jun-2021 Merger/Acquisition Clinics/Outpatient Services
To view AliveCor’s complete acquisitions history, request access »

AliveCor FAQs

  • When was AliveCor founded?

    AliveCor was founded in 2010.

  • Where is AliveCor headquartered?

    AliveCor is headquartered in Mountain View, CA.

  • What is the size of AliveCor?

    AliveCor has 178 total employees.

  • What industry is AliveCor in?

    AliveCor’s primary industry is Monitoring Equipment.

  • Is AliveCor a private or public company?

    AliveCor is a Private company.

  • What is AliveCor’s current revenue?

    The current revenue for AliveCor is .

  • How much funding has AliveCor raised over time?

    AliveCor has raised $318M.

  • Who are AliveCor’s investors?

    GE HealthCare Technologies, Pegasus Tech Ventures, Sweetwater Private Equity, Huami Corp, and Mayo Clinic are 5 of 12 investors who have invested in AliveCor.

  • Who are AliveCor’s competitors?

    Agatsa, CardioDiagnostics, BodiMetrics, Huinno, and EHRV are some of the 16 competitors of AliveCor.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »